| __timestamp | Alnylam Pharmaceuticals, Inc. | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 23068000 |
| Thursday, January 1, 2015 | 41097000 | 33277000 |
| Friday, January 1, 2016 | 47159000 | 184902000 |
| Sunday, January 1, 2017 | 76545000 | 437411000 |
| Monday, January 1, 2018 | 73106000 | 827478000 |
| Tuesday, January 1, 2019 | 194688000 | 934678000 |
| Wednesday, January 1, 2020 | 414801000 | 951266000 |
| Friday, January 1, 2021 | 704143000 | 1382097000 |
| Saturday, January 1, 2022 | 868601000 | 1553153000 |
| Sunday, January 1, 2023 | 1517886000 | 1757661000 |
| Monday, January 1, 2024 | 1924873000 | 2168701000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, Alnylam Pharmaceuticals and Exelixis, Inc. have emerged as key players, each carving out a unique path to profitability. Over the past decade, Exelixis has consistently outperformed Alnylam in terms of gross profit, with a staggering 6600% increase from 2014 to 2023. Alnylam, while trailing, has shown impressive growth, achieving a 2900% rise in the same period.
This comparison highlights the diverse strategies and market dynamics shaping the biotech industry today.
Novo Nordisk A/S and Exelixis, Inc.: A Detailed Gross Profit Analysis
Merck & Co., Inc. and Exelixis, Inc.: A Detailed Gross Profit Analysis
Alnylam Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited: A Detailed Gross Profit Analysis
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Alkermes plc
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and Veracyte, Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Vericel Corporation
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Gross Profit Analysis: Comparing Exelixis, Inc. and Halozyme Therapeutics, Inc.
Gross Profit Analysis: Comparing Exelixis, Inc. and Jazz Pharmaceuticals plc
Who Generates Higher Gross Profit? Exelixis, Inc. or Supernus Pharmaceuticals, Inc.